A Cost Variation Analysis of Various Statin Preparations Available in the Egyptian Market
Bulletin of Faculty of Pharmacy Cairo University, Vol: 61, Issue: 2
2024
- 229Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage229
- Downloads153
- Abstract Views76
Article Description
Introduction: Dyslipidemia is one of the main risk factors for cardiovascular diseases. Statin preparations are the most effective lipid-lowering preparations that reduce the risk of mortality related to cardiovascular diseases. In the Egyptian market, various statin preparations have different strengths and prices. Aim: The current study aims to assess the percentage of cost variations among different statin medications in the Egyptian market. Methods: This is a cost variation study conducted from November to December 2022. The data were collected by using the Egyptian master on therapeutic drugs, edition 2022, and from the Egyptian Drug Database (DDB) website. The maximum and the minimum price of various statin agents were calculated. The price of each statin preparation was calculated per unit dose. The percentage of cost variations was calculated using the formula: Cost variation (%) = (maximum cost- minimum cost)/minimum cost ×100. Results: The maximum percentage of the cost variation was found between Atorvastatin preparations of 10 mg (776.9%) followed by atorvastatin agents of 20 mg (406.3%). Meanwhile, the minimum price variation was in Lovastatin preparations of 10 mg (11.1%), followed by Lovastatin of 40 mg (18.5%). Conclusion: The present study highlighted a wide range of cost variations between statin preparations, especially for Atorvastatin and Rosuvastatin. Further studies are recommended to recognize the reasons for high-cost variations among statin preparations and how to overcome those reasons. Physicians must consider the cost of the prescribed drug to improve the patients’ adherence to the treatment.
Bibliographic Details
Faculty of Pharmacy Cairo University
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know